| 11/03/2026 3:08 PM | Rhythm Pharmaceuticals (1649904) Filer | Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
| 11/03/2026 7:10 AM | Rhythm Pharmaceuticals (1649904) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 10/13/2026 12:37 PM | JPMORGAN CHASE & CO (19617) Filed by JPMORGAN CHASE & CO (19617) Filed by JPMORGAN CHASE & CO (19617) Filed by JPMORGAN CHASE & CO (19617) Filed by Rhythm Pharmaceuticals (1649904) Subject | Form SCHEDULE 13G | |
| 09/14/2026 6:37 PM | Meeker David P (1385155) Reporting Rhythm Pharmaceuticals (1649904) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 09/14/2026 3:49 PM | Meeker David P (1385155) Reporting Rhythm Pharmaceuticals (1649904) Subject | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 09/01/2026 3:22 PM | Rhythm Pharmaceuticals (1649904) Issuer Smith Hunter C (1636385) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 08/31/2026 3:32 PM | Rhythm Pharmaceuticals (1649904) Subject Smith Hunter C (1636385) Reporting | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 08/18/2026 4:35 PM | Joshi Manher (1978048) Reporting Rhythm Pharmaceuticals (1649904) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 08/18/2026 4:17 PM | Joshi Manher (1978048) Reporting Rhythm Pharmaceuticals (1649904) Issuer | Form 3 Initial statement of beneficial ownership of securities | |
| 08/17/2026 4:57 PM | Garfield Alastair (2027261) Reporting Rhythm Pharmaceuticals (1649904) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 08/17/2026 5:00 PM | Rhythm Pharmaceuticals (1649904) Issuer Shulman Joseph (1909855) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
Get the Latest News and Ratings for RYTM and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Rhythm Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter.
|
| 08/14/2026 6:01 PM | Mazabraud Yann (1774702) Reporting Rhythm Pharmaceuticals (1649904) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 08/14/2026 6:04 PM | Lee Jennifer Kayden (1801372) Reporting Rhythm Pharmaceuticals (1649904) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 08/13/2026 3:40 PM | Rhythm Pharmaceuticals (1649904) Subject Shulman Joseph (1909855) Reporting | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 08/13/2026 3:51 PM | Garfield Alastair (2027261) Reporting Rhythm Pharmaceuticals (1649904) Subject | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 08/12/2026 3:34 PM | Mazabraud Yann (1774702) Reporting Rhythm Pharmaceuticals (1649904) Subject | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 08/11/2026 3:30 PM | Cramer Pamela J. (1873517) Reporting Rhythm Pharmaceuticals (1649904) Subject | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 08/10/2026 3:33 PM | Cramer Pamela J. (1873517) Reporting Rhythm Pharmaceuticals (1649904) Subject | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 08/04/2026 3:05 PM | Rhythm Pharmaceuticals (1649904) Filer | Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
| 08/04/2026 6:49 AM | Rhythm Pharmaceuticals (1649904) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 06/25/2026 5:08 PM | MCGIRR DAVID W J (1219023) Reporting Rhythm Pharmaceuticals (1649904) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 06/25/2026 5:09 PM | JEAN CHRISTOPHE (1378435) Reporting Rhythm Pharmaceuticals (1649904) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 06/25/2026 5:01 PM | GOOD JENNIFER L (1229245) Reporting Rhythm Pharmaceuticals (1649904) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 06/25/2026 5:03 PM | Arbuckle Stuart A (1557290) Reporting Rhythm Pharmaceuticals (1649904) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 06/25/2026 5:06 PM | Rhythm Pharmaceuticals (1649904) Issuer TETRAULT LYNN A. (1645512) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 06/25/2026 3:46 PM | Rhythm Pharmaceuticals (1649904) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 06/24/2026 3:15 PM | Rhythm Pharmaceuticals (1649904) Issuer TETRAULT LYNN A. (1645512) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 06/22/2026 3:49 PM | Rhythm Pharmaceuticals (1649904) Subject TETRAULT LYNN A. (1645512) Reporting | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 06/15/2026 3:07 PM | Rhythm Pharmaceuticals (1649904) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 05/20/2026 3:15 PM | Rhythm Pharmaceuticals (1649904) Issuer Smith Hunter C (1636385) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 05/05/2026 3:18 PM | Rhythm Pharmaceuticals (1649904) Filer | Form DEFA14A | |
| 05/05/2026 6:48 AM | Rhythm Pharmaceuticals (1649904) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 04/30/2026 11:56 AM | Rhythm Pharmaceuticals (1649904) Subject VANGUARD CAPITAL MANAGEMENT LLC (2100119) Filed by | Form SCHEDULE 13G | |
| 04/03/2026 4:34 PM | Popovits Kimberly J (1333482) Reporting Rhythm Pharmaceuticals (1649904) Issuer | Form 3 Initial statement of beneficial ownership of securities | |
| 04/03/2026 4:35 PM | Popovits Kimberly J (1333482) Reporting Rhythm Pharmaceuticals (1649904) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 04/03/2026 4:36 PM | Mazabraud Yann (1774702) Reporting Rhythm Pharmaceuticals (1649904) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 04/03/2026 2:06 PM | Rhythm Pharmaceuticals (1649904) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 03/27/2026 10:33 AM | Rhythm Pharmaceuticals (1649904) Subject VANGUARD GROUP INC (102909) Filed by | Form SCHEDULE 13G/A | |
| 03/20/2026 8:20 AM | Rhythm Pharmaceuticals (1649904) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 03/16/2026 3:11 PM | Mathers Edward T (1328625) Reporting Rhythm Pharmaceuticals (1649904) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 03/06/2026 3:51 PM | German Christopher Paul (1260835) Reporting Rhythm Pharmaceuticals (1649904) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
Why I'm selling my Snapback Indicator for just $7 (Ad) For Black Friday, Base Camp Trading's Thomas Wood is offering lifetime access to his proprietary Snapback Indicator for a single $7 payment. Others previously paid $500.
The indicator flashes a Crash Alert as a cue to exit or go short, and a Bull Run Alert as a cue to buy or go long.
No strings attached, and Wood says there is an unusual reason behind the steep discount. Get lifetime access to the Snapback Indicator for a one-time $7 payment today. |
| 03/04/2026 7:22 PM | Mazabraud Yann (1774702) Reporting Rhythm Pharmaceuticals (1649904) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 03/04/2026 3:40 PM | Mathers Edward T (1328625) Reporting Rhythm Pharmaceuticals (1649904) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 03/03/2026 6:45 PM | German Christopher Paul (1260835) Reporting Rhythm Pharmaceuticals (1649904) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 03/02/2026 7:56 PM | Rhythm Pharmaceuticals (1649904) Issuer Smith Hunter C (1636385) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 03/02/2026 5:01 AM | Rhythm Pharmaceuticals (1649904) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 02/26/2026 4:37 PM | Rhythm Pharmaceuticals (1649904) Filer | Form S-3ASR | |
| 02/26/2026 4:16 PM | Rhythm Pharmaceuticals (1649904) Filer | Form S-8 Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
| 02/26/2026 6:30 AM | Rhythm Pharmaceuticals (1649904) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 02/19/2026 8:02 PM | Rhythm Pharmaceuticals (1649904) Issuer Smith Hunter C (1636385) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 02/13/2026 4:48 PM | German Christopher Paul (1260835) Reporting Rhythm Pharmaceuticals (1649904) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 02/13/2026 4:49 PM | Lee Jennifer Kayden (1801372) Reporting Rhythm Pharmaceuticals (1649904) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 02/13/2026 4:50 PM | Mazabraud Yann (1774702) Reporting Rhythm Pharmaceuticals (1649904) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 02/13/2026 4:52 PM | Meeker David P (1385155) Reporting Rhythm Pharmaceuticals (1649904) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 02/13/2026 4:53 PM | Rhythm Pharmaceuticals (1649904) Issuer Shulman Joseph (1909855) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 02/13/2026 4:47 PM | Garfield Alastair (2027261) Reporting Rhythm Pharmaceuticals (1649904) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 02/13/2026 4:45 PM | Cramer Pamela J. (1873517) Reporting Rhythm Pharmaceuticals (1649904) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 02/12/2026 7:56 PM | Rhythm Pharmaceuticals (1649904) Issuer Smith Hunter C (1636385) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 02/06/2026 5:38 PM | Rhythm Pharmaceuticals (1649904) Issuer Smith Hunter C (1636385) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 02/03/2026 3:35 PM | Rhythm Pharmaceuticals (1649904) Issuer Shulman Joseph (1909855) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 02/03/2026 3:36 PM | Rhythm Pharmaceuticals (1649904) Issuer Smith Hunter C (1636385) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 02/03/2026 3:38 PM | Mazabraud Yann (1774702) Reporting Rhythm Pharmaceuticals (1649904) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 01/30/2026 1:43 PM | Rhythm Pharmaceuticals (1649904) Subject VANGUARD GROUP INC (102909) Filed by | Form SCHEDULE 13G/A | |
| 01/16/2026 6:50 AM | Rhythm Pharmaceuticals (1649904) Filer | Form S-8 Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
| 01/09/2026 8:06 AM | Rhythm Pharmaceuticals (1649904) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 12/19/2025 3:05 PM | Rhythm Pharmaceuticals (1649904) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 12/11/2025 3:25 PM | Cramer Pamela J. (1873517) Reporting Rhythm Pharmaceuticals (1649904) Subject | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 12/11/2025 6:50 AM | Rhythm Pharmaceuticals (1649904) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 11/24/2025 3:15 PM | Cramer Pamela J. (1873517) Reporting Rhythm Pharmaceuticals (1649904) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 11/20/2025 3:23 PM | Cramer Pamela J. (1873517) Reporting Rhythm Pharmaceuticals (1649904) Subject | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |